Silver Book Fact

Slowing the Progress of Parkinson’s Disease Would Save Money

Fact image

An Economic Model of Parkinson’s Disease: Implications for slowing progression in the United States. Mov Disorders. 2013; 28(3). https://onlinelibrary.wiley.com/doi/abs/10.1002/mds.25328

Reference

Title
An Economic Model of Parkinson’s Disease: Implications for slowing progression in the United States
Publication
Mov Disorders
Publication Date
2013
Volume & Issue
Volume 28, Issue 3
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • 32 drugs are currently in development for Parkinson’s disease.  
  • If the progression of Parkinson’s disease were slowed by 50%, there would be a 35% reduction in excess costs.  
  • A medicine is in development that aims to prevent or reverse Alzheimer’s disease progression by using a human monoclonal antibody specifically designed to remove beta amyloid protein from the brain.  
  • An Alzheimer’s disease treatment breakthrough that slowed its progression and began to show its effects in 2015, would reduce the Medicare costs for people with the disease in 2050 by…  
  • Donepezil, a cholinesterase inhibitor, has been found to slow progression of Alzheimer’s disease in its early stages, delaying the need for nursing home care by an average of 30 months.